Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 24;68(20):458-462.
doi: 10.15585/mmwr.mm6820a3.

Progress Toward Polio Eradication - Worldwide, January 2017-March 2019

Progress Toward Polio Eradication - Worldwide, January 2017-March 2019

Sharon A Greene et al. MMWR Morb Mortal Wkly Rep. .

Abstract

Since the Global Polio Eradication Initiative (GPEI) began in 1988, transmission of wild poliovirus (WPV) has been interrupted in all countries except Afghanistan, Nigeria, and Pakistan. WPV type 2 (WPV2) was declared eradicated in 2015; WPV type 3 has not been detected since 2012 (1). After the certification of the eradication of WPV2, a global switch from trivalent oral poliovirus vaccine (tOPV, containing vaccine virus types 1, 2, and 3) to bivalent oral poliovirus vaccine (bOPV, containing types 1 and 3) was completed in April 2016. Nigeria last reported WPV type 1 (WPV1) cases in 2016. This report describes global progress toward poliomyelitis eradication during January 1, 2017-March 31, 2019, and updates previous reports (1,2). Afghanistan and Pakistan reported their lowest annual number of WPV cases (22) in 2017; however, 33 WPV1 cases were reported in 2018. During January-March 2019 (as of May 3), 12 WPV1 cases had been reported worldwide, four more than the eight reported during the corresponding period in 2018. The occurrence of polio cases caused by circulating vaccine-derived poliovirus (cVDPV) is rare and occurs where oral poliovirus vaccine (OPV) coverage has been low and vaccine virus reverts to neurovirulence (3). Eight countries (Democratic Republic of the Congo [DRC], Indonesia, Mozambique, Niger, Nigeria, Papua New Guinea, Somalia, and Syria) reported 210 cVDPV cases during 2017-2019 (as of May 3). Reaching children during supplemental immunization activities (SIAs), accessing mobile populations at high risk, and variations in surveillance performance represent ongoing challenges. Innovative efforts to vaccinate every child and strengthen coordination efforts between Afghanistan and Pakistan will help achieve eradication. For cVDPV outbreak responses to promptly stop transmission, intensified programmatic improvements are needed to make the responses more effective and limit the risk for generating future outbreaks.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Number of cases of wild poliovirus, by country and month of onset — worldwide, January 2016–March 2019 * As of May 3, 2019.

Similar articles

Cited by

References

    1. Khan F, Datta SD, Quddus A, et al. Progress toward polio eradication—worldwide, January 2016–March 2018. MMWR Morb Mortal Wkly Rep 2018;67:524–8. 10.15585/mmwr.mm6718a4 - DOI - PMC - PubMed
    1. Morales M, Tangermann RH, Wassilak SGF. Progress toward polio eradication—worldwide, 2015–2016. MMWR Morb Mortal Wkly Rep 2016;65:470–3. 10.15585/mmwr.mm6518a4 - DOI - PubMed
    1. Jorba J, Diop OM, Iber J, et al. Update on vaccine-derived polioviruses—worldwide, January 2017–June 2018. MMWR Morb Mortal Wkly Rep 2018;67:1189–94. 10.15585/mmwr.mm6742a5 - DOI - PMC - PubMed
    1. Hsu C, Mahamud A, Safdar M, et al. Progress toward poliomyelitis eradication—Pakistan, January 2017–September 2018. MMWR Morb Mortal Wkly Rep 2018;67:1242–5. 10.15585/mmwr.mm6744a5 - DOI - PMC - PubMed
    1. Martinez M, Shukla H, Ahmadzai M, et al. Progress toward poliomyelitis eradication—Afghanistan, January 2017–August 2018. MMWR Morb Mortal Wkly Rep 2018;67:833–7. 10.15585/mmwr.mm6730a6 - DOI - PMC - PubMed

MeSH terms

Substances